National University Hospital of Cheng Kung in Taiwan and the United States national institutes of health jointly develop a new treatment for heroin addiction based on a drug that is used to slow the progression of Alzheimer's disease.
Both these institutions have discovered, when every day consume less than five milligrams of Alzheimer's drugs, Ebixa (memantine), will be able to help heroin addicts use to reduce dependence on transitional therapy methadon methadon.
The drug is Methadon substitution of heroin and used to reduce the craving in heroin and any other actual opiates.
In clinical testing for three months by the hospital to the patient who is addicted to heroin, 90 found that 48 of them using the show a decreased reliance on Ebixa methadon, while 42 other patients who consumed a placebo became increasingly dependent on methadon.
In addition, Ebixa seem effective in protecting and regenerate nerves and noted that the researchers also noted the existence of a reduction in the number of neurotoxin (nerve poison) and such as perforin (cell poisons) in patients using the drug.
Transitional therapy, which started to use methadon in Taiwan since 2004, limited to eliminate drug addiction due to replace the sense of actual opiates anesthetic for a moment with actual opiates lasting, like methadon.
The hospital has taken a patent for the invention of memantine at play "protecting nerve degeneration caused by inflammation of the dopamine" in the United States and the European Union.
Dopamine nerve can be damaged by the use of the methadon, causing dependence on a substance, and Lu said that the discovery could help more people cured of addiction in the future if the new treatment was successfully promoted.
Both these institutions have discovered, when every day consume less than five milligrams of Alzheimer's drugs, Ebixa (memantine), will be able to help heroin addicts use to reduce dependence on transitional therapy methadon methadon.
The drug is Methadon substitution of heroin and used to reduce the craving in heroin and any other actual opiates.
In clinical testing for three months by the hospital to the patient who is addicted to heroin, 90 found that 48 of them using the show a decreased reliance on Ebixa methadon, while 42 other patients who consumed a placebo became increasingly dependent on methadon.
In addition, Ebixa seem effective in protecting and regenerate nerves and noted that the researchers also noted the existence of a reduction in the number of neurotoxin (nerve poison) and such as perforin (cell poisons) in patients using the drug.
Transitional therapy, which started to use methadon in Taiwan since 2004, limited to eliminate drug addiction due to replace the sense of actual opiates anesthetic for a moment with actual opiates lasting, like methadon.
The hospital has taken a patent for the invention of memantine at play "protecting nerve degeneration caused by inflammation of the dopamine" in the United States and the European Union.
Dopamine nerve can be damaged by the use of the methadon, causing dependence on a substance, and Lu said that the discovery could help more people cured of addiction in the future if the new treatment was successfully promoted.
0 comments:
Post a Comment